Literature DB >> 4155974

The action of indoramin and other compounds on the uptake of neurotransmitters into rat cortical slices.

R F Sugden.   

Abstract

Indoramin has been tested for its ability to inhibit the uptake of tritiated (-)-noradrenaline and 5-hydroxytryptamine into rat brain cortical slices. Other alpha-blocking agents and tricycic antidepressants were included for comparison. Activity against noradrenaline uptake is probably not important in the therapeutic action of indoramin. However, inhibition of 5-hydroxytryptamine uptake may be responsible for the sedation in high dosage noted by some investigators,

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155974      PMCID: PMC1776773          DOI: 10.1111/j.1476-5381.1974.tb10687.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  [COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS WITH TOFRANIL, PERTOFRAN AND INSIDON].

Authors:  W THEOBALD; O BUECH; H A KUNZ; C MORPURGO; E G STENGER; G WILHELMI
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-04-01

2.  Clinical evaluation of indoramin, a new antihypertensive agent.

Authors:  P J Lewis; C F George; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

Review 3.  Clinical use of psychotherapeutic drugs: current status.

Authors:  L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1969 Mar-Apr       Impact factor: 6.875

4.  The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.

Authors:  P Lidbrink; G Jonsson; K Fuxe
Journal:  Neuropharmacology       Date:  1971-09       Impact factor: 5.250

5.  The effect of imipramine on central 5-hydroxytryptamine neurons.

Authors:  A Carlsson; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1968-02       Impact factor: 3.765

6.  Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.

Authors:  G Jonsson; B Hamberger; T Malmfors; C Sachs
Journal:  Eur J Pharmacol       Date:  1969-10       Impact factor: 4.432

7.  The uptake of [3H]GABA by slices of rat cerebral cortex.

Authors:  L L Iversen; M J Neal
Journal:  J Neurochem       Date:  1968-10       Impact factor: 5.372

8.  The evaluation of the alpha-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparations.

Authors:  M G Collis; B J Alps
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

  8 in total
  12 in total

1.  Pharmacokinetic studies on WY 23409 HCl.

Authors:  A J Swaisland; R A Franklin; R J Southgate
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

Review 2.  A basis for migraine therapy- the autonomic theory reappraised.

Authors:  E S Johnson
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

3.  Proceedings of the Fiftieth Anniversary Meeting of the British Pharmacological Society, University of Oxford, 16-18 September 1981. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

4.  Assessment of Peripheral adrenergic activity and its interactions with drugs in man.

Authors:  K Ghose
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

5.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

6.  Antidepressant activity and pharmacological interactions of ciclazindol.

Authors:  K Ghose; V A Rama Rao; J Bailey; A Coppen
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

7.  Intravenous tyramine response in migraine before and during treatment with indoramin.

Authors:  K Ghose; A Coppen; D Carrol
Journal:  Br Med J       Date:  1977-05-07

8.  Comparison of the effects of chronic administration of ciclazindol and desipramine on pupillary responses to tyramine, methoxamine and pilocarpine in healthy volunteers.

Authors:  F A Kerr; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

9.  Sympathetic mechanisms in diet-induced thermogenesis: modification by ciclazindol and anorectic drugs.

Authors:  N J Rothwell; M J Stock; M G Wyllie
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

10.  The pharmacokinetics of ciclazindol (Wy 23409) in human volunteers.

Authors:  A J Swaisland; R A Franklin; P J Southgate; A J Coleman
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.